Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-030810
Filing Date
2025-04-01
Accepted
2025-04-01 21:54:08
Documents
1
Period of Report
2025-03-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2511110-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2511110-7_4seq1.xml 4 9852
  Complete submission text file 0001104659-25-030810.txt   11431
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LEAP THERAPEUTICS 47 THORNDIKE STREET, SUITE B1-1 CAMBRIDGE MA 02141
Business Address
Granfield Christine (Reporting) CIK: 0001822190 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 25801823